PREVIOUS QUESTION:

 

NEXT QUESTION:

 

How does Provenge treat advanced prostate cancer?

ANSWER

If hormone therapy ultimately fails to slow the growth of the cancer, the next step may be a prostate cancer "vaccine" called Provenge (sipuleucel-T). Most men who take Provenge survive at least two years after starting the treatment. Provenge is a therapy created by taking immune cells from a patient, genetically engineering them to fight prostate cancer, and then putting them back into the patient. It's used for men with few or no symptoms and when advanced prostate cancer no longer responds to hormone therapy.

SOURCES: 

Prostate Cancer Foundation. 

National Institutes of Health.

American Cancer Society web site.

News release, Astellas Pharma Inc.

Reviewed by William Blahd on July 11, 2017

SOURCES: 

Prostate Cancer Foundation. 

National Institutes of Health.

American Cancer Society web site.

News release, Astellas Pharma Inc.

Reviewed by William Blahd on July 11, 2017

NEXT QUESTION:

How does Xofigo treat advanced prostate cancer?

WAS THIS ANSWER HELPFUL

THIS TOOL DOES NOT PROVIDE MEDICAL ADVICE. It is intended for general informational purposes only and does not address individual circumstances. It is not a substitute for professional medical advice, diagnosis or treatment and should not be relied on to make decisions about your health. Never ignore professional medical advice in seeking treatment because of something you have read on the WebMD Site. If you think you may have a medical emergency, immediately call your doctor or dial 911.

    This tool does not provide medical advice. See additional information.

    Other Answers On: